Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $167.7M | -- | -- | -$0.32 | -- |
| 11/04/2025 | Q3 | $229.7M | $240.2M | -$0.00 | $0.22 | -$0.22 |
| 08/04/2025 | Q2 | $159M | $167.9M | -$0.18 | -$0.29 | $0.11 |
| 04/30/2025 | Q1 | $151.3M | $179.7M | -$0.00 | -$0.12 | $0.12 |
| 02/27/2025 | Q4 | $131.7M | $148.6M | -$0.48 | -$0.29 | -$0.19 |
| 11/05/2024 | Q3 | $193.7M | $206M | $0.34 | $0.19 | $0.16 |
| 08/08/2024 | Q2 | $136.1M | $136.5M | -$0.48 | -$0.25 | -$0.24 |
| 04/30/2024 | Q1 | $149.7M | $153.6M | -$0.10 | -$0.04 | -$0.05 |
| 02/28/2024 | Q4 | $127.2M | $125.4M | -$0.53 | -$0.28 | -$0.25 |
| 11/02/2023 | Q3 | -- | $176M | $0.09 | -- | -- |
| 07/27/2023 | Q2 | -- | $124.8M | -$0.48 | -- | -- |
| 05/03/2023 | Q1 | -- | $143.4M | -$0.01 | -- | -- |
| 02/28/2023 | Q4 | -- | $118M | -$0.63 | -- | -- |
| 11/02/2022 | Q3 | -- | $144.8M | -$0.18 | -- | -- |
| 08/01/2022 | Q2 | -- | $90.9M | -$0.59 | -- | -- |
| 05/03/2022 | Q1 | -- | $67.8M | -$0.85 | -- | -- |
| 02/22/2022 | Q4 | -- | $65.6M | -$0.55 | -- | -- |
| 11/02/2021 | Q3 | -- | $64.5M | -$0.51 | -- | -- |
| 08/03/2021 | Q2 | -- | $15.3M | -$0.73 | -- | -- |
| 04/29/2021 | Q1 | -- | $1.8M | -$0.69 | -- | -- |
| 03/09/2021 | Q4 | -- | $367K | -$0.62 | -- | -- |
| 10/29/2020 | Q3 | -- | $1M | -$0.56 | -- | -- |
| 08/10/2020 | Q2 | -- | -$268K | -$0.80 | -- | -- |
| 05/01/2020 | Q1 | -- | $81.2M | -$0.04 | -- | -- |
| 02/25/2020 | Q4 | -- | $75.8M | -$0.03 | -- | -- |
| 10/30/2019 | Q3 | -- | $101M | -$0.01 | -- | -- |
| 08/01/2019 | Q2 | -- | $76.7M | $0.02 | -- | -- |
| 05/02/2019 | Q1 | -- | $89.7M | $0.31 | -- | -- |
| 02/28/2019 | Q4 | -- | $70.6M | -$0.10 | -- | -- |
| 11/02/2018 | Q3 | -- | $87.2M | $0.11 | -- | -- |
| 08/02/2018 | Q2 | -- | $69.5M | $0.00 | -- | -- |
| 05/03/2018 | Q1 | -- | $82.4M | $0.24 | -- | -- |
| 02/28/2018 | Q4 | -- | $63.2M | -$0.36 | -- | -- |
| 11/07/2017 | Q3 | -- | $84.6M | $0.20 | -- | -- |
| 08/03/2017 | Q2 | -- | $55.6M | -$0.06 | -- | -- |
| 05/09/2017 | Q1 | -- | $63.1M | $0.01 | -- | -- |
| 03/07/2017 | Q4 | -- | $56.1M | -$0.19 | -- | -- |
| 11/04/2016 | Q3 | -- | $70.8M | $0.16 | -- | -- |
| 08/08/2016 | Q2 | -- | $53.9M | -$0.10 | -- | -- |
| 03/31/2016 | Q1 | -- | $61.6M | $0.23 | -- | -- |
| 12/31/2015 | Q4 | -- | $46.5M | -$0.01 | -- | -- |
Lindblad Expeditions Holdings, Inc. reported $240.2M worth of top line sales in its most recent quarter.
Lindblad Expeditions Holdings, Inc. announced earnings per share of -$0.00 which represents a miss of analyst forecast a $0.22 per share.
Lindblad Expeditions Holdings, Inc. reported $100.9M that represents $1.82 per share over the last quarter.
Lindblad Expeditions Holdings, Inc.'s earnings are forecast to decrease from -$0.67 per share to -$0.42 per share next year representing a decrease of -29.29%.
Lindblad Expeditions Holdings, Inc.'s next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.